Health Condition 1: H350- Background retinopathy and retinalvascular changes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: a.Males or females 18 years of age or older b. Patients who had consented to share their data for research & development. c. Confirmed diagnosis of type 1 or type 2 diabetes mellitus. d. Patients with the following stages of DR Stages and the respective distribution: i. No DR (15%) ii. Mild Non-Proliferative DR (20%) iii. Moderate Non-Proliferative DR (25%) iv. Severe Non-Proliferative DR (25%) v. Proliferative DR (10%) vi. Presence of Diabetic Macular Edema (5%)
Exclusion criteria
Exclusion criteria: a.Patients who had not consented to share their data for research and development purposes. b. Known history (in last 6 months from date of acquisition) of retinal artery or vein occlusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The study aims to analyze OCTA data and clinical details from 200 diabetic patients using the ZEISS CIRRUS HD-OCT 5000. The outcome will provide insights into diabetic retinopathy characteristics and progression. Findings may contribute to better understanding and management of diabetic eye disease.Timepoint: Collection of Single-Visit data from Cirrus HD-OCT 5000 device. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Carl Zeiss India (Bangalore) Private Limited